Physician profile
Henry Igdal
NPI 1346259280
$800.96
in general payments reported to CMS, 2019-2025
10 companies · $91.49 in 2025
The $91.49 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $109 · 2021: $61.14 · 2022: $284 · 2023: $97.84 · 2024: $41.60 · 2025: $91.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $269.19 | 2019-2025 | Nuplazid |
| Avanir Pharmaceuticals, INC. | $172.11 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $142.01 | 2022-2025 | |
| Lilly USA, LLC | $60.24 | 2020-2021 | |
| Mylan Specialty L.P. | $45.44 | 2022-2024 | Yupelri |
| Viatris Specialty LLC | $39.08 | 2025 | Yupelri |
| Sun Pharmaceutical Industries INC. | $29.31 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $17.23 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.47 | 2023 | Austedo |
| Glaxosmithkline, LLC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Igdal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.